Details:

Alternative Title:
Emerg Infect Dis
Personal Author:
Temperton, Nigel J. ; Chan, Paul K. ; Simmons, Graham ; Zambon, Maria C. ; Tedder, Richard S. ; ... More +
Temperton, Nigel J. ; Chan, Paul K. ; Simmons, Graham ; Zambon, Maria C. ; Tedder, Richard S. ; Takeuchi, Yasuhiro ; Weiss, Robin A. Less -
Description:
The severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike protein (S) is a major target for neutralizing antibodies. Retroviral SARS-CoV S pseudotypes have been constructed and used to develop an in vitro microneutralization assay that is both sensitive and specific for SARS-CoV neutralizing antibodies. Neutralization titers measured by this assay are highly correlated to those measured by an assay using replication-competent SARS-CoV. No cross-neutralization occurred with human sera known to contain antibodies to coronavirus strains OC43 and 229E. The pseudotype assay was used to profile neutralizing antibody responses against SARS-CoV S in sequential serum samples taken from 41 confirmed SARS patients during the 2003 outbreak in Hong Kong and shows long-lasting immunity in most recovered patients. The pseudotype assay does not require handling live SARS virus; it is a useful tool to determine neutralizing titers during natural infection and the preclinical evaluation of candidate vaccines.
Subject:
[+]
Adolescent Adult Aged Aged, 80 And Over Antibodies, Viral Cell Line Child Emerging Female Humans Infectious Diseases Leukemia Virus, Murine Longitudinal Studies Male Membrane Glycoproteins Middle Aged Neutralization Tests Research SARS Virus Severe Acute Respiratory Syndrome Spike Glycoprotein, Coronavirus Vaccines Viral Envelope Proteins SARS Virus
Source:
Emerg Infect Dis. 11(3):411-416.
Document Type:
Journal Article
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:a5d1d2c8560195450d9fd7e30bf64502309696451849c08834b7ad605533bb0b
Download URL:
https://stacks.cdc.gov/view/cdc/15710/cdc_15710_DS1.pdf
File Type:

Supporting Files

• 	04-0906.nxml	txt
  	license.txt	txt
  	04-0906-F1.gif	gif
  	04-0906-F1.jpg	jpeg
  	04-0906-F2.gif	gif
  	04-0906-F2.jpg	jpeg
  	04-0906-F3.gif	gif
  	04-0906-F3.jpg	jpeg
  	04-0906-F4.gif	gif
  	04-0906-F4.jpg	jpeg

More +